TECX today
$21.14+$0.10 (+0.48%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourLeaning Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns up above $61.07
Key levels
Resistance$22.80
Resistance$21.44
Support$18.54
Support$16.77
Latest news & SEC filings
EarningsTectonic Therapeutic, Inc. Posts Q3 2026 Financial Results
SEC FilingTectonic Therapeutic, Inc. filed a report on a major company event (Form 8-K)
EarningsTectonic Therapeutic posts smaller Q3 loss than expected
All TECX news →About Tectonic Therapeutic
Tectonic Therapeutic is a clinical-stage biotechnology company that creates protein and antibody therapies aimed at G-protein coupled receptors. Its main candidate, TX45, is a relaxin-based fusion protein being tested in patients with pulmonary hypertension linked to heart failure, while TX2100 is an antibody candidate for a genetic bleeding disorder called hereditary hemorrhagic telangiectasia. The company relies on its GEODe discovery platform and conducts its operations mainly in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Tectonic Therapeutic, Inc. (TECX)
What Is the Price Target for TECX?
SEPT Low Target
$26.00
SEPT Mid Target
$78.00
SEPT High Target
$93.00
Analyst Consensus
$78.00
Is TECX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TECX.
Start Free Trial →Is TECX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$66.20
12
Moat Score
NONE
4/9
Piotroski Score
20.4
Altman Z-Score
What Is Smart Money Doing with TECX?
Insider Signal
SELLING
2 buys / 7 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| REICIN ALISE | director officer | Buy | 10,000 | $24K | Oct 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TECX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
40.7%
FCF Growth YoY
-1.8%
Revenue Trend
UNKNOWN
Dark Pool Trades for TECX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TECX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:38:33 | $20.60 | 59,500 | $$1.2M | SELL |
| 20:36:47 | $20.50 | 23,500 | $$482K | BUY |
| 19:53:55 | $20.51 | 8,468 | $$174K | SELL |
| 19:36:49 | $20.50 | 1,000 | $$21K | SELL |
| 16:18:22 | $20.49 | 1,000 | $$20K | BUY |
5 dark pool trades shown · $$1.9M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Tectonic Therapeutic, Inc. (TECX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TECX — frequently asked questions
What is TECX stock price today?
Tectonic Therapeutic, Inc. (TECX) is at $21.14, up 0.48% (+$0.10) at the Nov 13, 2026 close.
Why is TECX stock moving today?
Latest TECX news — Nov 5, 2026: Tectonic Therapeutic, Inc. Posts Q3 2026 Financial Results · Nov 5, 2026: Tectonic Therapeutic, Inc. filed a report on a major company event (Form 8-K)
What is the TECX price target?
The average analyst price target for TECX is $78.00, ranging from $26 to $93, based on 4 analysts. Latest: UBS initiates on Oct 12, 2026.
What do analysts rate TECX?
Analyst ratings for TECX: 1 Buy, 3 Hold, 0 Sell — consensus Hold.
Did TECX beat earnings?
TECX last reported on Aug 6, 2026: EPS -$1.18 vs -$1.35 expected — a beat of 12.6%.
Does TECX pay a dividend?
TECX does not currently pay a dividend.
What are TECX support and resistance levels?
Support: $18.54, $16.77. Resistance: $21.44, $22.80, $24.65.
What are insiders doing with TECX?
Insider activity: SELLING, 2 buys and 7 sells in the last 90 days.
What is the latest news on TECX?
Nov 5, 2026: Tectonic Therapeutic, Inc. Posts Q3 2026 Financial Results · Nov 5, 2026: Tectonic Therapeutic, Inc. filed a report on a major company event (Form 8-K) · Nov 5, 2026: Tectonic Therapeutic posts smaller Q3 loss than expected